<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03969290</url>
  </required_header>
  <id_info>
    <org_study_id>CLE383-P001</org_study_id>
    <nct_id>NCT03969290</nct_id>
  </id_info>
  <brief_title>Clinical Performance of Two Daily Disposable Contact Lenses - Study 1</brief_title>
  <official_title>Clinical Performance of Two Daily Disposable Contact Lenses - Study 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate end of day (EOD) visual acuity (VA) at distance when
      wearing Precision1™ contact lenses compared to Acuvue® Moist contact lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The expected duration of subject participation in the study is 1-8 days, with 3 scheduled
      visits (Screening, Dispense, Exit).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 5, 2019</start_date>
  <completion_date type="Actual">August 5, 2019</completion_date>
  <primary_completion_date type="Actual">August 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Contralateral</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>End of day (EOD) visual acuity at distance</measure>
    <time_frame>Day 1, after 8 hours of wear</time_frame>
    <description>Visual acuity (VA) will be measured in &quot;logarithm of the minimum angle of resolution&quot; (logMAR). A lower logMAR value indicates better visual acuity.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>Sequence 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Verofilcon A contact lens in the right eye (OD), with etafilcon A contact lens in the left eye (OS), as randomized. Lenses will be worn for one day, approximately 8 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sequence 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Etafilcon A contact lens in the right eye (OD), with verofilcon A contact lens in the left eye (OS), as randomized. Lenses will be worn for one day, approximately 8 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Verofilcon A contact lenses</intervention_name>
    <description>Daily disposable silicone hydrogel contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia)</description>
    <arm_group_label>Sequence 1</arm_group_label>
    <arm_group_label>Sequence 2</arm_group_label>
    <other_name>Precision1™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Etafilcon A contact lenses</intervention_name>
    <description>Daily disposable contact lenses indicated for the optical correction of refractive ametropia (myopia and hyperopia)</description>
    <arm_group_label>Sequence 1</arm_group_label>
    <arm_group_label>Sequence 2</arm_group_label>
    <other_name>Acuvue® Moist</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to understand and sign an approved Informed Consent form

          -  Successful wear of spherical soft contact lenses for distance correction in both eyes
             during the past 3 months for a minimum of 5 days per week and 8 hours per day

          -  Best corrected VA of logMAR 0.10 or better in each eye

          -  Willing to discontinue artificial tears and rewetting drops during the study

          -  Able to wear contact lenses within the protocol-specified sphere power range

          -  Other protocol-specified inclusion criteria may apply.

        Exclusion Criteria:

          -  Any anterior segment infection, inflammation, or abnormality or disease that
             contraindicates contact lens wear, as determined by the Investigator

          -  Any use of systemic or ocular medications for which contact lens wear could be
             contraindicated, as determined by the Investigator

          -  History of ocular or intraocular surgery, including refractive surgery, and/or
             irregular cornea

          -  Wearing habitual contact lenses in an extended wear modality (routinely sleeping in
             lenses for at least 1 night per week) over the last 3 months prior to enrollment

          -  Previous 3 years or current wearers of Acuvue Moist or DAILIES TOTAL1® contact lenses

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alcon Research</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alcon Investigative Site</name>
      <address>
        <city>Jena</city>
        <zip>07745</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 29, 2019</study_first_submitted>
  <study_first_submitted_qc>May 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>August 20, 2019</last_update_submitted>
  <last_update_submitted_qc>August 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact lens</keyword>
  <keyword>Vision correction</keyword>
  <keyword>Visual acuity</keyword>
  <keyword>Daily disposable contact lens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

